These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16869770)

  • 21. Reduced expression of the cyclin-dependent kinase inhibitor gene p57KIP2 in Wilms' tumor.
    Thompson JS; Reese KJ; DeBaun MR; Perlman EJ; Feinberg AP
    Cancer Res; 1996 Dec; 56(24):5723-7. PubMed ID: 8971182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor.
    Ravenel JD; Broman KW; Perlman EJ; Niemitz EL; Jayawardena TM; Bell DW; Haber DA; Uejima H; Feinberg AP
    J Natl Cancer Inst; 2001 Nov; 93(22):1698-703. PubMed ID: 11717330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the IGF2/H19 imprinting control region uncovers new genetic defects, including mutations of OCT-binding sequences, in patients with 11p15 fetal growth disorders.
    Demars J; Shmela ME; Rossignol S; Okabe J; Netchine I; Azzi S; Cabrol S; Le Caignec C; David A; Le Bouc Y; El-Osta A; Gicquel C
    Hum Mol Genet; 2010 Mar; 19(5):803-14. PubMed ID: 20007505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic imprinting and cancer.
    Tycko B
    Results Probl Cell Differ; 1999; 25():133-69. PubMed ID: 10339745
    [No Abstract]   [Full Text] [Related]  

  • 25. Alterations of H19 imprinting and IGF2 replication timing are infrequent in Beckwith-Wiedemann syndrome.
    Squire JA; Li M; Perlikowski S; Fei YL; Bayani J; Zhang ZM; Weksberg R
    Genomics; 2000 May; 65(3):234-42. PubMed ID: 10857747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extensive investigation of the IGF2/H19 imprinting control region reveals novel OCT4/SOX2 binding site defects associated with specific methylation patterns in Beckwith-Wiedemann syndrome.
    Abi Habib W; Azzi S; Brioude F; Steunou V; Thibaud N; Das Neves C; Le Jule M; Chantot-Bastaraud S; Keren B; Lyonnet S; Michot C; Rossi M; Pasquier L; Gicquel C; Rossignol S; Le Bouc Y; Netchine I
    Hum Mol Genet; 2014 Nov; 23(21):5763-73. PubMed ID: 24916376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent IGF2/H19 domain epigenetic alterations and elevated IGF2 expression in epithelial ovarian cancer.
    Murphy SK; Huang Z; Wen Y; Spillman MA; Whitaker RS; Simel LR; Nichols TD; Marks JR; Berchuck A
    Mol Cancer Res; 2006 Apr; 4(4):283-92. PubMed ID: 16603642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microdeletion and IGF2 loss of imprinting in a cascade causing Beckwith-Wiedemann syndrome with Wilms' tumor.
    Prawitt D; Enklaar T; Gärtner-Rupprecht B; Spangenberg C; Lausch E; Reutzel D; Fees S; Korzon M; Brozek I; Limon J; Housman DE; Pelletier J; Zabel B
    Nat Genet; 2005 Aug; 37(8):785-6; author reply 786-7. PubMed ID: 16049499
    [No Abstract]   [Full Text] [Related]  

  • 29. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour.
    Steenman MJ; Rainier S; Dobry CJ; Grundy P; Horon IL; Feinberg AP
    Nat Genet; 1994 Jul; 7(3):433-9. PubMed ID: 7920665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic differences between Wilms' tumours in white and east-Asian children.
    Fukuzawa R; Breslow NE; Morison IM; Dwyer P; Kusafuka T; Kobayashi Y; Becroft DM; Beckwith JB; Perlman EJ; Reeve AE
    Lancet; 2004 Feb; 363(9407):446-51. PubMed ID: 14962525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour.
    Astuti D; Latif F; Wagner K; Gentle D; Cooper WN; Catchpoole D; Grundy R; Ferguson-Smith AC; Maher ER
    Br J Cancer; 2005 Apr; 92(8):1574-80. PubMed ID: 15798773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice.
    Sakatani T; Kaneda A; Iacobuzio-Donahue CA; Carter MG; de Boom Witzel S; Okano H; Ko MS; Ohlsson R; Longo DL; Feinberg AP
    Science; 2005 Mar; 307(5717):1976-8. PubMed ID: 15731405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relaxation of IGF2 imprinting in Wilms tumours associated with specific changes in IGF2 methylation.
    Sullivan MJ; Taniguchi T; Jhee A; Kerr N; Reeve AE
    Oncogene; 1999 Dec; 18(52):7527-34. PubMed ID: 10602511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imprinting status of 11p15 genes in Beckwith-Wiedemann syndrome patients with CDKN1C mutations.
    Li M; Squire J; Shuman C; Fei YL; Atkin J; Pauli R; Smith A; Nishikawa J; Chitayat D; Weksberg R
    Genomics; 2001 Jun; 74(3):370-6. PubMed ID: 11414765
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch.
    Li T; Vu TH; Ulaner GA; Littman E; Ling JQ; Chen HL; Hu JF; Behr B; Giudice L; Hoffman AR
    Mol Hum Reprod; 2005 Sep; 11(9):631-40. PubMed ID: 16219628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parental genomic imprinting.
    Deal CL
    Curr Opin Pediatr; 1995 Aug; 7(4):445-58. PubMed ID: 7581651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic and genetic alterations of the imprinting disorder Beckwith-Wiedemann syndrome and related disorders.
    Soejima H; Higashimoto K
    J Hum Genet; 2013 Jul; 58(7):402-9. PubMed ID: 23719190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor risk.
    Kaneda A; Feinberg AP
    Cancer Res; 2005 Dec; 65(24):11236-40. PubMed ID: 16357124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome.
    Weksberg R; Shen DR; Fei YL; Song QL; Squire J
    Nat Genet; 1993 Oct; 5(2):143-50. PubMed ID: 8252039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of IGF2 imprinting: mechanisms and consequences.
    Ohlsson R
    Novartis Found Symp; 2004; 262():108-21; discussion 121-4, 265-8. PubMed ID: 15562825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.